BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15136396)

  • 1. Influence of i.v. haloperidol on ventricular repolarization and monophasic action potential duration in anesthetized dogs.
    Rasty S; Amin NB; Sabbah HN; Mishima T; Borzak S; Tisdale JE
    Chest; 2004 May; 125(5):1821-9. PubMed ID: 15136396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the acute electrophysiologic effects of intravenous dronedarone, an amiodarone-like agent, with special emphasis on ventricular repolarization and acquired torsade de pointes arrhythmias.
    Verduyn SC; Vos MA; Leunissen HD; van Opstal JM; Wellens HJ
    J Cardiovasc Pharmacol; 1999 Feb; 33(2):212-22. PubMed ID: 10028928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiological effects of MS-551, a new class III agent: comparison with dl-sotalol in dogs.
    Sen L; Cui G; Sakaguchi Y; Singh BN
    J Pharmacol Exp Ther; 1998 May; 285(2):687-94. PubMed ID: 9580614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency-dependent effects of quinidine on the relationship between action potential duration and refractoriness in the canine heart in situ.
    Franz MR; Costard A
    Circulation; 1988 May; 77(5):1177-84. PubMed ID: 3359594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrial-specific drug AVE0118 is free of torsades de pointes in anesthetized dogs with chronic complete atrioventricular block.
    Oros A; Volders PG; Beekman JD; van der Nagel T; Vos MA
    Heart Rhythm; 2006 Nov; 3(11):1339-45. PubMed ID: 17074641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of intravenous haloperidol on QT interval dispersion in critically ill patients: comparison with QT interval prolongation for assessment of risk of Torsades de Pointes.
    Tisdale JE; Rasty S; Padhi ID; Sharma ND; Rosman H
    J Clin Pharmacol; 2001 Dec; 41(12):1310-8. PubMed ID: 11762558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monophasic action potentials in patients with torsades de pointes.
    Miwa S; Inoue T; Yokoyama M
    Jpn Circ J; 1994 Apr; 58(4):248-58. PubMed ID: 8051783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of chronic treatment by amiodarone on transmural heterogeneity of canine ventricular repolarization in vivo: interactions with acute sotalol.
    Merot J; Charpentier F; Poirier JM; Coutris G; Weissenburger J
    Cardiovasc Res; 1999 Nov; 44(2):303-14. PubMed ID: 10690307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Influence of pacing site on myocardial transmural dispersion of repolarization in intact normal and dilated cardiomyopathy dogs].
    Bai R; Pu J; Liu N; Lu JG; Zhou Q; Ruan YF; Niu HY; Wang L
    Sheng Li Xue Bao; 2003 Dec; 55(6):722-30. PubMed ID: 14695492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the rate dependent effects of dofetilide and ibutilide in the newborn heart.
    Pickoff AS; Stolfi A
    Pacing Clin Electrophysiol; 2001 May; 24(5):816-23. PubMed ID: 11388101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measurement variability of right atrial and ventricular monophasic action potential and refractory period measurements in the standing non-sedated horse.
    De Clercq D; Broux B; Vera L; Decloedt A; van Loon G
    BMC Vet Res; 2018 Mar; 14(1):101. PubMed ID: 29558937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemodynamic and electrophysiological effects of mitemcinal (GM-611), a novel prokinetic agent derived from erythromycin in a halothane-anesthetized canine model.
    Kimura K; Tabo M; Mizoguchi K; Kato A; Suzuki M; Itoh Z; Omura S; Takanashi H
    J Toxicol Sci; 2007 Aug; 32(3):231-9. PubMed ID: 17785940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of a typical I(Kr) channel blocker sematilide on the relationship between ventricular repolarization, refractoriness and onset of torsades de pointes.
    Sugiyama A; Hashimoto K
    Jpn J Pharmacol; 2002 Apr; 88(4):414-21. PubMed ID: 12046984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency-dependent electrophysiological effect of ibutilide on human atrium and ventricle.
    Oshikawa N; Watanabe I; Masaki R; Shindo A; Kojima T; Saito S; Ozawa Y; Kanmatsuse K
    J Interv Card Electrophysiol; 2001 Mar; 5(1):81-7. PubMed ID: 11248779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of sustained load on dispersion of ventricular repolarization and conduction time in the isolated intact rabbit heart.
    Zabel M; Portnoy S; Franz MR
    J Cardiovasc Electrophysiol; 1996 Jan; 7(1):9-16. PubMed ID: 8718979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency-dependent electrophysiologic effects of amiodarone in humans.
    Sager PT; Uppal P; Follmer C; Antimisiaris M; Pruitt C; Singh BN
    Circulation; 1993 Sep; 88(3):1063-71. PubMed ID: 8353868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of thoracic epidural anesthesia with and without autonomic nervous system blockade on cardiac monophasic action potentials and effective refractoriness in awake dogs.
    Meissner A; Eckardt L; Kirchhof P; Weber T; Rolf N; Breithardt G; Van Aken H; Haverkamp W
    Anesthesiology; 2001 Jul; 95(1):132-8; discussion 6A. PubMed ID: 11465550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual rate-dependent cardiac electrophysiologic effects of haloperidol: slowing of intraventricular conduction and lengthening of repolarization.
    Mörtl D; Agneter E; Krivanek P; Koppatz K; Todt H
    J Cardiovasc Pharmacol; 2003 Jun; 41(6):870-9. PubMed ID: 12775964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of K201 on repolarization and arrhythmogenesis in anesthetized chronic atrioventricular block dogs susceptible to dofetilide-induced torsade de pointes.
    Stams TR; Oros A; der Nagel Rv; Beekman JD; Chamberlin P; Dittrich HC; Vos MA
    Eur J Pharmacol; 2011 Dec; 672(1-3):126-34. PubMed ID: 22001562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe proarrhythmic potential of risperidone compared to quetiapine in an experimental whole-heart model of proarrhythmia.
    Frommeyer G; von der Ahe H; Brücher B; Dechering DG; Lange PS; Reinke F; Wasmer K; Köbe J; Pott C; Mönnig G; Eckardt L
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Oct; 389(10):1073-80. PubMed ID: 27405774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.